The Senate Judiciary Committee’s Intellectual Property Subcommittee held a critical hearing on the Patent Eligibility Restoration Act of 2025 (PERA), a bipartisan bill that seeks to restore clarity to ...

Jason P Rogers of James & Wells provides a guide to protecting pharmaceutical and biotech inventions in New Zealand, and previews the changes expected under proposed changes to the Patents Act In New ...

Masato Iida of Shiga International Patent Office explains how the inventive step obstacle can be cleared when preparing a patent application and presents several case studies based on combination ...

New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedical and Genetics industry ...

As AI tools become more prevalent in the life sciences, biotechnology companies need to evaluate AI’s impact on their ability to protect the results of their research. Recent U.S. Patent and Trademark ...

Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...

Artificial intelligence is beginning to transform patent practice, but for chemistry and biotech, the challenges remain unique. How well do today’s AI tools truly understand complex scientific ...

The Amendment to the Taiwan Patent Act is expected to come into effect in November 2012. As the government endeavours to stimulate the growth of the biotech and pharmaceutical industries in Taiwan, ...